Neuphoria Therapeutics Inc.

NASDAQ (USD): Neuphoria Therapeutics Inc. (NEUP)

Last Price

5.09

Today's Change

-0.01 (0.19%)

Day's Change

4.75 - 5.24

Trading Volume

87,957

Overview

Market Cap

8 Million

Shares Outstanding

1 Million

Avg Volume

1,317,131

Avg Price (50 Days)

3.70

Avg Price (200 Days)

6.78

PE Ratio

-63.62

EPS

-0.08

Earnings Announcement

13-Mar-2025

Previous Close

5.10

Open

5.23

Day's Range

4.75 - 5.24

Year Range

2.124 - 16.08

Trading Volume

87,957

Price Change Highlight

1 Day Change

-0.20%

5 Day Change

1.19%

1 Month Change

49.71%

3 Month Change

122.27%

6 Month Change

-25.58%

Ytd Change

73.72%

1 Year Change

-53.09%

3 Year Change

-96.37%

5 Year Change

-97.12%

10 Year Change

-97.12%

Max Change

-97.12%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical - Pharmaceuticals

Description:

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment